Branch Chief Vijay Kumar Named Acting Head Of US FDA’s Cell, Gene Therapy Office

 
• By Derrick Gingery
CBER named an acting director of OTP two days after ousting director Nicole Verdun. (Shutterstock)

More from US FDA

More from Advanced Technologies